Company intelligence / Profile preview

BloomedIn

Ownership: Private
Development stage: Preclinical

Overview

Bloomage Biotech is a global leader in the industrial-scale production of hyaluronic acid using proprietary microbial fermentation. Its products are widely used as pharmaceutical ingredients, medical device components, cosmetic actives, and dietary supplements. The company has developed nearly 200 specifications of hyaluronic acid and several other bioactive compounds. It supplies both pharmaceutical-grade APIs/excipients and consumer-facing ingredients for health and beauty applications. No clinical trial results are reported as the business focuses on ingredient manufacturing rather than drug development pipelines.

Therapeutic areas: OtherDermatologyRheumatologyOphthalmology
Modalities: Biologic (hyaluronic acid)Small molecule (gamma aminobutyric acid/GABA)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on BloomedIn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BloomedIn.

Explore the full profile